Grail, Inc. (NASDAQ:GRAL) CFO Sells $426,937.04 in Stock

Grail, Inc. (NASDAQ:GRAL) CFO Aaron Freidin sold 30,452 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares in the company, valued at $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Grail Price Performance

Shares of NASDAQ GRAL traded up $0.79 during midday trading on Tuesday, hitting $14.79. The stock had a trading volume of 416,469 shares, compared to its average volume of 1,090,092. The company’s 50 day simple moving average is $13.84. Grail, Inc. has a 1 year low of $12.33 and a 1 year high of $23.36.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on GRAL. Wolfe Research began coverage on shares of Grail in a report on Friday. They set a “peer perform” rating on the stock. Guggenheim began coverage on shares of Grail in a report on Thursday, October 17th. They set a “neutral” rating on the stock.

About Grail

GRAIL, Inc, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.